Free Trial

Seer, Inc. (NASDAQ:SEER) Director Dipchand Nishar Sells 30,253 Shares

Seer logo with Medical background

Seer, Inc. (NASDAQ:SEER - Get Free Report) Director Dipchand Nishar sold 30,253 shares of the firm's stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $2.08, for a total value of $62,926.24. Following the completion of the sale, the director now owns 49,204 shares in the company, valued at approximately $102,344.32. This represents a 38.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Seer Stock Performance

Shares of NASDAQ:SEER traded down $0.05 during trading on Monday, reaching $2.02. The company had a trading volume of 191,278 shares, compared to its average volume of 330,609. The firm's fifty day moving average is $2.03 and its 200 day moving average is $2.14. The firm has a market capitalization of $118.92 million, a PE ratio of -1.55 and a beta of 1.54. Seer, Inc. has a twelve month low of $1.56 and a twelve month high of $2.63.

Seer (NASDAQ:SEER - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.37) by $0.03. The firm had revenue of $4.21 million during the quarter, compared to analyst estimates of $3.25 million. Seer had a negative return on equity of 21.96% and a negative net margin of 565.83%. Equities analysts predict that Seer, Inc. will post -1.42 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Seer

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Y Intercept Hong Kong Ltd acquired a new position in shares of Seer in the 4th quarter worth approximately $36,000. Corient Private Wealth LLC lifted its stake in Seer by 66.0% during the fourth quarter. Corient Private Wealth LLC now owns 33,200 shares of the company's stock valued at $77,000 after purchasing an additional 13,200 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Seer by 27.0% during the fourth quarter. Renaissance Technologies LLC now owns 843,700 shares of the company's stock worth $1,949,000 after buying an additional 179,568 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Seer by 4.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 127,711 shares of the company's stock worth $295,000 after buying an additional 5,000 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. acquired a new position in Seer in the fourth quarter worth approximately $179,000. 75.20% of the stock is owned by institutional investors and hedge funds.

About Seer

(Get Free Report)

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Seer Right Now?

Before you consider Seer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.

While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines